Brentuximab vedotin, sold under the brand name Adcetris, is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic …

Monomethyl auristatin E (MMAE) is a synthetic antineoplastic agent. Because of its toxicity, it cannot be used as a drug itself; instead, it is linked to a monoclonal antibody (MAB) which …

Feb 29, 2024 · Brentuximab vedotin is used in adults and children at least 2 years old to treat classical Hodgkin lymphoma. Brentuximab vedotin is also used in adults to treat anaplastic …

Levothyroxine is a synthetic T4 hormone used to treat hypothyroidism that can be used along with surgery and radioiodine therapy to manage thyrotropin-dependent well-differentiated thyroid …

Brentuximab vedotin is used in: Adults whose cancer is systemic and has not gotten better after treatment with combination chemotherapy. Adults whose cancer has not been treated. …

Brentuximab vedotin is an ADC and selectively targets CD30 antigen on the surface of the cancer cells. It is composed of the chimeric human-murine IgG1 antibody that selectively targets cell …

Dec 10, 2017 · Brentuximab vedotin is an anti-CD30 antibody–drug conjugate that has been approved for relapsed and refractory Hodgkin’s lymphoma.

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML): Patients treated with ADCETRIS can have a rare, serious brain infection called PML that can lead to death.

Brentuximab vedotin is used in combination with other chemotherapy in pediatric patients 2 years or older as first treatment for Hodgkin lymphoma. Brentuximab vedotin injection is in a class of …

What is this drug used for? It is used to treat lymphoma. What do I need to tell my doctor BEFORE I take this drug? If you are allergic to this drug; any part of this drug; or any other …